Inpatient hyperglycemia management: the opportunities of a new basal insulin
The management of hospitalized diabetic patients for any cause is often difficult and affected not only by the comorbidities of the patient but also by the hospital setting. It is well known that at the admission the antidiabetic drugs should be discontinued on behalf of insulin therapy with insulin...
Main Author: | Natalino Simioni |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2016-06-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | http://www.italjmed.org/index.php/ijm/article/view/681 |
Similar Items
-
Low fasting glucose‐to‐estimated average glucose ratio was associated with superior response to insulin degludec/aspart compared with basal insulin in patients with type 2 diabetes
by: Han Na Jang, et al.
Published: (2022-01-01) -
Future of newer basal insulin
by: S V Madhu, et al.
Published: (2013-01-01) -
Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
by: Han Na Jang, et al.
Published: (2019-12-01) -
Modern basal insulins: an ongoing story or the start of a new era?
by: Ivan Ivanovich Dedov
Published: (2015-12-01) -
Individualisation of basal insulin therapy of type 2 diabetes: evidence from large randomized controlled trials
by: S. V. Nedogoda, et al.
Published: (2023-01-01)